Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$62.68 - $95.05 $157,201 - $238,385
2,508 New
2,508 $235,000
Q4 2021

Feb 14, 2022

SELL
$72.5 - $100.68 $181,250 - $251,700
-2,500 Closed
0 $0
Q3 2021

Nov 02, 2021

BUY
$90.24 - $124.05 $225,600 - $310,125
2,500 New
2,500 $239,000
Q2 2021

Aug 12, 2021

SELL
$93.66 - $139.27 $177,954 - $264,613
-1,900 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$99.61 - $142.12 $189,259 - $270,028
1,900 New
1,900 $252,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Empirical Financial Services, LLC D.B.A. Empirical Wealth Management Portfolio

Follow Empirical Financial Services, LLC D.B.A. Empirical Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empirical Financial Services, LLC D.B.A. Empirical Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Empirical Financial Services, LLC D.B.A. Empirical Wealth Management with notifications on news.